Clinical Trials Browser

Phase 2/3 × Burkitt Lymphoma × blinatumomab × Clear all

NCT06882057 2025-08-26

CCCG-LR-B-ALL

Phase 2/3 Recruiting

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma